News

Since January 1, 2026, the National Medical Products Administration's new export certificate rules have taken effect, as reported by NMPA Announcement No. 113 (2025). The key provision: drugs manufactured to GMP standards – even if not yet approved for domestic sale – can now obtain export certificates, removing a major bureaucratic hurdle. This is particularly significant for companies like FS Pharma that focus primarily on exports. Previously, we had to navigate complex domestic approval processes even for products destined entirely for overseas markets, adding years of delay. The new rules cut through that red tape. FS Pharma Perspective: This policy change is transformative for our product pipeline. We can now introduce new biologicals and formulations to emerging markets faster, without waiting for domestic registration. Our GMP certifications already meet international standards – this rule validates our compliance efforts. The 2026 Government Work Report naming biomedicine an "emerging pillar industry" further signals strong state support. We are already leveraging this to accelerate registration of our hepatitis vaccines in several African countries. Combined with RCEP tariff reductions and regional procurement platforms, this policy significantly lowers barriers to entry, especially in ASEAN and Central Asian markets.  

China's pharmaceutical foreign trade expanded steadily in the first half of 2026, with total value reaching US$104.32 billion – a 6.4% year-on-year increase, according to customs data cited by China Pharmaceutical News (Aug 13, 2026). Exports grew at a faster clip of 9.9% to US$59.97 billion, signaling strong overseas demand.   Two trends stand out for suppliers like FS Pharma: medical devices (up 12.5%) and western pharmaceuticals (up 8.4%) led the pack, with disposable consumables surging 17.1%. This aligns with FS Pharma's own growth in vacuum blood collection tubes and essential biologicals.   FOSDHAN Pharma Perspective: The acceleration from 5.5% Q1 growth to 14% Q2 growth reflects not just seasonality but deepening market penetration in emerging economies. For our core products – tetanus antitoxin, rabies vaccines, and hepatitis vaccines – we see parallel demand surges in Africa and Southeast Asia, where public health spending is rising. The shift toward higher-value exports validates our strategy to emphasize biologicals over bulk APIs.   We interpret the data as a clear signal that global buyers increasingly trust Chinese pharmaceutical quality. FOSHAN Pharma's 20+ years of export experience position us to capture this upswing, especially in regions where we have established distributor networks.

We are proud to announce the launch of our high-quality Enoxaparin Sodium Injection, a trusted low molecular weight heparin designed for effective antithrombotic therapy. This medication is widely indicated for the prophylaxis of deep vein thrombosis (DVT), particularly in patients undergoing orthopedic or general abdominal surgeries. It is also utilized in the treatment of established DVT, with or without pulmonary embolism, and for managing unstable angina and non-Q-wave myocardial infarction in conjunction with aspirin.   Our Enoxaparin Sodium Injection is available in two precise specifications to meet diverse clinical needs: 0.4ml:4000 IU and 0.6ml:6000 IU. Each package contains 2 pre-filled syringes, ensuring convenience, accurate dosing, and enhanced safety for healthcare professionals and patients.   By offering this essential medication, we remain committed to providing reliable, high-standard pharmaceutical solutions that support cardiovascular health and improve patient outcomes. For more detailed prescribing information, please consult the full product label.    

We are proud to introduce our high-quality Purple Cap EDTA K2/K3 Blood Collection Tubes, designed to meet the rigorous demands of modern clinical laboratories. Featuring a distinct purple cap for easy identification, these vacuum tubes are the premier choice for general hematology tests, including complete blood counts (CBC), blood typing, and glycosylated hemoglobin analysis.   Manufactured from durable PET or glass, our tubes are pre-coated with either EDTA-K2 or EDTA-K3 anticoagulant. This advanced formulation effectively chelates calcium ions to prevent clotting while comprehensively protecting blood cell morphology and volume. The smooth inner walls ensure optimal mixing, and the secure safety caps guarantee specimen integrity.   Backed by strict quality control and international certifications, our EDTA tubes deliver precise, reliable results. Trust our innovative solutions to elevate your diagnostic accuracy and streamline your blood collection procedures.  

We are proud to highlight our Hepatitis A (Live) Vaccine, Freeze-dried, a vital tool in preventing hepatitis A worldwide. Manufactured using a highly stable, attenuated virus strain cultured in human diploid cells, this vaccine is rigorously purified to ensure exceptional safety and efficacy.   Clinical data demonstrates that a single dose stimulates robust and long-lasting immune responses in both children and adults, with an excellent safety profile and minimal adverse reactions. Its advanced freeze-dried formulation guarantees superior stability for convenient storage and transport.   Committed to "quality first and innovation," we continue to supply high-standard vaccines to domestic and international markets, dedicated to protecting public health and advancing global disease prevention efforts.    

FOSHAN PHARMA is proud to introduce our high-quality Anti-A & Anti-B Blood Grouping Reagents (Monoclonal Antibody). Designed for precise ABO blood typing, these reagents deliver exceptional accuracy and reliability for clinical and research applications. To maintain optimal performance and stability, our products must be stored at 2~8°C in the dark, ensuring long-term efficacy. We are committed to providing top-tier diagnostic solutions to meet your laboratory needs. For detailed product specifications, pricing, or to place an order, please feel free to contact our sales team. We welcome your inquiries and look forward to supporting your success!  

FOSHAN PHARMA CO., LTD. proudly launches its hospital-grade gauze bandage series to serve worldwide medical institutions and first-aid markets.   Made of degreased pure cotton, the gauze bandage features outstanding air permeability and strong liquid absorption, with soft texture that avoids skin irritation. It comes in sterile and non-sterile versions, multiple sizes for surgical dressing, injury fixation and daily wound care.   All products are produced in dust-free cleanrooms under strict ISO and CE standards. Custom sizes and packaging are available for bulk orders. FOSHAN PHARMA sticks to reliable, cost-effective medical consumables to safeguard wound recovery for every user.        

Our medical device firm proudly launches full-series disposable infusion sets for global medical institutions. Made of medical-grade non-toxic PVC-free materials, the product features smooth liquid flow, precise flow regulators and sharp, pain-reduced venipuncture needles.   All items pass ISO and CE certifications with strict sterile production standards to cut infection risks. Suitable for hospitals, clinics and home care, our infusion sets balance safety, cost-efficiency and easy operation. We supply stable bulk orders worldwide, committed to reliable IV therapy solutions for patients globally.          

Our company launches high-quality Mannitol Injection, a sterile intravenous solution widely applied in clinical practice. Our mainstream specifications include 20ml:4g, 100ml:20g and 250ml:50g.   As a potent tissue dehydrant and osmotic diuretic, it is primarily used to relieve cerebral edema and reduce intracranial pressure. It also helps lower elevated intraocular pressure, promote diuresis for acute kidney issues, and accelerate excretion of toxic substances. All products meet strict pharmaceutical standards for safe clinical use.

Our company has rolled out a limited-time special promotion for our key product, Recombinant Hepatitis B Vaccine, offering exclusive discounted rates for immediate purchases.     The featured Recombinant Hepatitis B Vaccine is supplied at a specification of 10 μg, with remaining shelf life of over 1 year to guarantee stable quality and efficacy. It is packaged in prefilled syringes with Chinese package, ensuring convenient clinical use and standard logistics circulation.     With a wide vaccination population ranging from newborns to adults, the vaccine fits various public health immunization and routine vaccination scenarios. The minimum order quantity is set at 4,800 syringes, ideal for bulk procurement by global pharmaceutical distributors and medical institutions.   Don’t miss the limited-time special discount. We welcome global partners to inquire and place orders to secure cost-effective high-quality vaccine supplies.

FOSHAN PHARMA CO.,LTD,is pleased to announce our participation in CPHI Shanghai 2026. We will be located at Booth E9D02 during the exhibition. A wide range of product samples will be displayed on-site, includingindwelling needle syringes, syringes, vitamin C effervescent tablets, tetanus antitoxin, varicella vaccines and lubricants. Our professional team will be available for product consultation and business communication. We sincerely welcome all global customers and industry partners to visit our booth for further cooperation. Booth No.: E9D02

      Our company launches a full range of premium medical syringes, designed to meet global clinical and healthcare demands.     Manufactured with medical-grade raw materials, our syringes feature high transparency, smooth pushing performance and tight sealing. Each product is strictly sterilized and produced in standardized clean workshops to ensure safety, hygiene and biocompatibility for medical use.     Available in multiple specifications, our syringes are suitable for injection, medication delivery and routine medical operations. We adhere to strict international quality standards, delivering reliable and cost-effective medical supplies for global partners and healthcare institutions.    

We are pleased to announce the official launch of our new-generation Prefilled Syringe. Adopting premium medical-grade materials, this product features excellent airtightness and sterile stability. It ensures precise dosing, simplifies clinical operation, and lowers contamination risks.     Ergonomically designed for easy handling by medical staff and patients, it suits vaccines, biologic drugs and routine injections. This new launch strengthens our medical delivery product lineup, delivering safer and more efficient solutions for global healthcare.  

We are pleased to announce the official launch of our upgraded blood collection bag on the official global platform.     Designed for medical supply chain excellence, this blood bag features advanced anti-coagulation treatment and a leak-proof structure. It meets international quality standards for safe blood storage and transportation, supporting reliable blood transfusion services worldwide.     Targeting markets including Mauritius, Jordan and the Philippines, the product ensures compliance with regional regulatory requirements. We remain committed to providing high-quality, safe medical devices to facilitate global healthcare access.     For more details, please contact our international business team.              

We are pleased to introduce our high-quality Hepatitis A Vaccine, a safe and effective solution for global immunization programs.   Produced under strict GMP standards, this vaccine offers strong, long-lasting protection against Hepatitis A virus with high immunogenicity and excellent stability. It features a reliable safety profile, convenient administration, and is suitable for children and adults aged 12 months and above.   Widely used in domestic and international markets, it supports public health prevention and control worldwide. We remain committed to providing accessible, high-quality vaccines to protect communities globally.

FOSHAN PHARMA CP.,LTD– Our company is pleased to officially launch its high-quality Tranexamic Acid Injection, a professional hemostatic drug designed to meet diverse clinical hemostasis needs. As a synthetic lysine derivative, this product relies on advanced production technology and strict quality control, providing reliable support for medical institutions and related partners. We sincerely welcome all customers to learn about and purchase our products.   Tranexamic Acid Injection is a potent antifibrinolytic hemostatic agent with a clear mechanism: it competitively binds to plasmin and plasminogen, inhibiting fibrin dissolution to achieve effective hemostasis. Compared with similar products, it boasts strong efficacy, long duration and wide applicability, and can penetrate the blood-brain barrier, making it more effective for central nervous system bleeding. Available in specifications of 2ml:0.1g, 5ml:0.25g and 5ml:0.5g, it applies to various bleeding caused by primary fibrinolysis, post-surgical bleeding of specific organs, thrombolytic drug overdose, and auxiliary treatment of hemophilia. It can also treat hereditary angioedema.   Adhering to the "quality first" principle, our company strictly follows national pharmaceutical standards, with a complete quality control system from raw material selection to product inspection. The product has passed strict tests, with low adverse reaction rates, ensuring safety and reliability. As a professional pharmaceutical enterprise, we provide professional technical support and efficient after-sales service. We sincerely invite all sectors to pay attention to our Tranexamic Acid Injection, learn more via our official website or sales team, and choose our high-quality hemostatic solutions.  

  2026 Global Medical Industry: Trends, Opportunities & Our Commitment As we enter 2026, the global medical industry is undergoing steady transformation, driven by stricter global standards, rising cross-border demand, and accelerated technological progress. The sector is moving toward greater standardization, supply chain stability, and global connectivity, creating clear growth opportunities for reliable medical suppliers and partners worldwide. Global Standards & Rising Market Demand Global regulatory bodies are continuously upgrading quality and safety standards for medical products, pushing the industry toward higher compliance and consistent quality. This shift eliminates substandard supply and rewards manufacturers with strict quality control and reliable delivery systems. Emerging markets across Africa, the Middle East, Asia, and Latin America are expanding healthcare infrastructure and scaling public medical procurement. This has driven stable, long-term demand for medical consumables, finished pharmaceutical products, and diagnostic supplies, the core segments we specialize in serving. Innovation & Global Partnerships Technological advancements have improved production efficiency and supply chain reliability, while high-quality Chinese medical products are gaining global recognition for their cost-effectiveness and consistent performance. More international buyers are choosing trusted Chinese suppliers for stable, compliant, and scalable medical supply solutions. International tenders for medical supplies have grown significantly in recent months, covering a full range of medical consumables and finished formulations for public health projects. We have built a proven track record in supporting these tenders, with flexible customization and on-time cross-border delivery. Our Commitment to Global Partners At FOSHAN PHARMA CO.,LTD, we prioritize quality, reliability, and long-term partnership. We focus on supplying compliant, high-standard medical consumables and finished pharmaceutical products, with dedicated support for international tenders and seamless cross-border supply chains. We understand the importance of timely delivery, strict compliance, and transparent communication for our overseas clients. We are committed to maintaining stable supply, adapting to market needs, and growing together with partners across the globe. We look forward to continuing our collaboration with global clients, supporting global healthcare development, and building a healthier, more sustainable future through reliable medical solutions.

At FOSHAN PHARMA CO.,LTD, we are proud to introduce our premium Alcohol Swabs, a versatile and essential sanitization solution designed to meet the rigorous hygiene demands of medical, personal, and professional use. Crafted with precision and adherence to international quality standards, our alcohol swabs deliver consistent, effective disinfection for daily and clinical scenarios alike.     Our Alcohol Swabs feature a professional-grade formulation with 70% isopropyl alcohol, the optimal concentration proven to kill 99.9% of common bacteria, fungi, and viruses while minimizing irritation to the skin. Each swab is made from soft, lint-free non-woven fabric, ensuring gentle contact with all skin types—even sensitive skin—without leaving residual fibers or debris. Individually sealed in a sterile, airtight foil packet, every swab retains its moisture and sanitizing potency, guaranteeing freshness and reliability from the first to the last use. The standard size of 6cm x 3cm offers ample coverage for targeted disinfection, making it easy to handle and apply to small surfaces and skin areas.     For inquiries and bulk pricing, please contact our sales team—we look forward to partnering with you!    

We are delighted to extend our warm invitation to you for the prestigious China CPHI 2026. As a premier global platform in the pharmaceutical sector, it gathers industry leaders, innovative minds, and cutting-edge advancements. At this event, you will have the opportunity to explore the latest industry trends, breakthrough technologies, and establish valuable connections with peers from around the world. Our team will be on-site with our latest product offerings and solutions, ready to engage with you. The exhibition will be held from June 16th to 18th, 2026 at the Shanghai New International Expo Centre. We are convinced that your presence will enrich the event, and we sincerely look forward to meeting you and showcasing our offerings at our booth.   Exhibition Information Exhibition Center: Shanghai New International Expo Center Booth Number: E9D02 Date: June 16th to 18th, 2026

13.3.2026, FOSHAN PHARMA CO.,LTD, a professional manufacturer and supplier of high-quality disposable medical consumables, is pleased to officially launch its premium medical collection products: Sterile Urine Collection Containers 100ml + 9ml Collection Vacutainers. Designed to meet the rigorous demands of clinical diagnostics, laboratory testing and medical sampling, these products combine reliable performance, strict sterility control and full regulatory compliance, delivering safe and efficient solutions for global medical institutions and laboratory users. Core Product Features & Specifications Our newly launched disposable collection products are engineered for clinical practicality and user convenience, with standardized, user-centric design to ensure accurate sampling and secure storage. Key product attributes are as follows: Type: Disposable, sterile medical collection devices, dedicated for single-use clinical sampling to eliminate cross-contamination risks Packaging: Individually wrapped packaging, maintaining sterility and facilitating easy storage, distribution and on-site use in medical scenarios Closure Design: Equipped with tight screw caps, providing a secure, leak-proof seal to prevent sample spillage, contamination and volatilization, ensuring sample integrity during transportation and storage Volume Markings: Clear transparent milliliter (ml) markings, enabling accurate sample volume reading and reducing operational errors in clinical and laboratory processes Regulatory Compliance: CE marked, fully compliant with EU MDR (Medical Device Regulation) and EN ISO international standards, meeting strict European and global medical device quality requirements Full Compliance & Supporting Documentation To guarantee product quality, safety and regulatory validity, we provide complete, authoritative supporting documentation for these products, fully satisfying customer procurement, customs clearance and clinical verification needs. The available documents include: ✔ Valid CE certificate for the above mentioned products (issued by an EU Notified Body) ✔ Declaration of Conformity ✔ Technical data sheet / product specification ✔ ISO 13485 certificate (company quality management system) ✔ Sample photos of labeling and packaging Product Application & Market Advantage These 9ml collection vacutainers and 100ml sterile urine collection containers are widely applicable in hospitals, clinical laboratories, diagnostic centers, physical examination institutions and other medical settings, supporting routine urine testing, blood sample collection and various clinical sampling operations. With strict sterile production, durable material selection and standardized manufacturing processes, the products deliver stable performance and cost-effective solutions, making them ideal for bulk procurement and long-term supply cooperation. Inquiry Invitation We warmly welcome global customers, distributors, medical institutions and laboratory partners to inquire about product details, request quotations, obtain supporting documents and check sample labeling & packaging information. Our professional sales team will provide timely, detailed responses and customized cooperation solutions to support your business needs. For inquiries and more product information, please contact our sales department via [contact email/phone/website]. We look forward to establishing long-term, win-win partnerships with you!